agilon health, inc. (AGL) stock
AGLNYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$115.20−1.55 (-1.33%)
Close on Nov 17, 2026Market cap $1.93BP/E –Yield –
agilon health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
agilon health's ebitda for the twelve months ending Jun 30, 2026 was -$281.28M. For fiscal 2025 it was -$434.64M. The highest annual figure on record is -$42.57M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$434.64M | – |
| FY2024 | Dec 31, 2024 | -$267.67M | – |
| FY2023 | Dec 31, 2023 | -$211.97M | – |
| FY2022 | Dec 31, 2022 | -$91.61M | – |
| FY2021 | Dec 31, 2021 | -$357.57M | – |
| FY2020 | Dec 31, 2020 | -$42.57M | – |
| FY2019 | Dec 31, 2019 | -$65.16M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $18.63M | – |
| Q1 FY2026 | Mar 31, 2026 | $10.78M | – |
| Q4 FY2025 | Dec 31, 2025 | -$186.86M | – |
| Q3 FY2025 | Sep 30, 2025 | -$123.84M | – |
| Q2 FY2025 | Jun 30, 2025 | -$108.71M | – |
| Q1 FY2025 | Mar 31, 2025 | -$15.23M | – |
| Q4 FY2024 | Dec 31, 2024 | -$101.61M | – |
| Q3 FY2024 | Sep 30, 2024 | -$127.29M | – |
| Q2 FY2024 | Jun 30, 2024 | -$37.44M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.33M | -129.0% |
| Q4 FY2023 | Dec 31, 2023 | -$159.15M | – |
| Q3 FY2023 | Sep 30, 2023 | -$35.22M | – |
| Q2 FY2023 | Jun 30, 2023 | -$24.68M | – |
| Q1 FY2023 | Mar 31, 2023 | $4.61M | +75.1% |
| Q4 FY2022 | Dec 31, 2022 | -$50.16M | – |
| Q3 FY2022 | Sep 30, 2022 | -$26.07M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.01M | – |
| Q1 FY2022 | Mar 31, 2022 | $2.63M | – |
| Q4 FY2021 | Dec 31, 2021 | -$22.53M | – |
| Q3 FY2021 | Sep 30, 2021 | -$31.69M | – |
| Q2 FY2021 | Jun 30, 2021 | -$294.78M | -14361.3% |
| Q1 FY2021 | Mar 31, 2021 | -$8.63M | – |
| Q4 FY2020 | Dec 31, 2020 | -$35.99M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.50M | – |
| Q2 FY2020 | Jun 30, 2020 | $2.07M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.47M | – |
See a number that looks wrong?